PHARMACOTHERAPY OF CHRONIC PULMONARY ARTERIAL-HYPERTENSION - VALUE AND LIMITATIONS .1. PRIMARY PULMONARY-HYPERTENSION

被引：7

作者：

ALPERT, MA

CONCANNON, MD

MUKERJI, B

MUKERJI, V

机构：

[1] Division of Cardiology, University of South Alabama, College of Medicine, Mobile, Alabama

来源：

ANGIOLOGY | 1994年 / 45卷 / 08期

关键词：

D O I：

10.1177/000331979404500801

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Efforts aimed at assessing pharmacotherapy of pulmonary arterial hypertension (PHT) have largely focused on patients with primary PHT, PHT associated with selected connective tissue diseases, and various forms of hypoxic secondary PHT. Part I of this review discusses the value and limitations of a wide variety of vasodilator drugs, oxygen, and warfarin in the treatment of primary PHT with special reference to their effects on pulmonary and systemic hemodynamics, functional capacity, and survival.

引用

页码：667 / 676

页数：10

共 94 条

[1]

ARNMAN K, 1984, ACTA MED SCAND, V215, P175

[2] HYPOTENSION AND SINUS ARREST WITH NIFEDIPINE IN PULMONARY-HYPERTENSION [J].